Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06279975

Pupillometric Evaluation in Patients Declared Brain Dead - a Prospective Quality Control Study

Investigative Neurological Study With Pupillometric Evaluation os a Clinical Tool in Patients Declared Brain Dead (INSPECT) - a Prospective Quality Control Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to verify the reliability of the current purely clinical examination of the pupils (without the support of a pupillometer) in the context of clinically suspected brain death, compared to the results of a non-invasive, automated, and highly precise monocular pupillometric examination.

Detailed description

This prospective quality control study will evaluate the reliability of the clinical exam regarding pupils' reaction to light (as performed by two board certified physicians in Neurology and/or Intensive Care Medicine) as recommended by the SAMW guidelines for brain death diagnosis (SAMW-guidelines) when compared to the results of a noninvasive automated and highly-precise pupillometry in adult patients with clinically suspected brain death. Automated pupillometric measurements will be performed by the PI (RS), or the co-investigator (Dr. Pascale Grzonka) using the NeurOptics® NPi®-200 pupillometer system immediately before and after the standardized diagnostic workup for suspected brain death. In addition, demographics, clinical characteristics , treatment and laboratory data from the patients examined will be anonymously collected.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTnon-invasive device-supported, automated pupillometrynon-invasive device-supported, automated pupillometry with a precise quantitative measurement of the pupils within the range of micrometers

Timeline

Start date
2023-12-18
Primary completion
2029-12-01
Completion
2030-12-01
First posted
2024-02-28
Last updated
2025-03-12

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06279975. Inclusion in this directory is not an endorsement.